David Orain

1.4k total citations
35 papers, 1.1k citations indexed

About

David Orain is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Orain has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Orain's work include Chemical Synthesis and Analysis (9 papers), Asymmetric Synthesis and Catalysis (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). David Orain is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Asymmetric Synthesis and Catalysis (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). David Orain collaborates with scholars based in Switzerland, United Kingdom and France. David Orain's co-authors include Mark Bradley, Fabrice Guillier, Samuel Hintermann, Klemens Kaupmann, Christine Guntermann, Joerg Kallen, Henri Mattes, Andreas Billich, Janet Dawson and Markus Fendt and has published in prestigious journals such as Chemical Reviews, PLoS ONE and Chemical Communications.

In The Last Decade

David Orain

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Orain Switzerland 17 606 500 147 102 99 35 1.1k
John M. Nuss United States 16 1.3k 2.1× 847 1.7× 64 0.4× 104 1.0× 145 1.5× 30 1.9k
Pei Xu China 26 437 0.7× 632 1.3× 119 0.8× 142 1.4× 108 1.1× 80 1.6k
Giuseppina Sabatino Italy 15 591 1.0× 277 0.6× 88 0.6× 88 0.9× 88 0.9× 53 1.1k
Edward R. Bacon United States 18 321 0.5× 453 0.9× 120 0.8× 38 0.4× 83 0.8× 57 988
Rebecca L. Maglathlin United States 9 802 1.3× 310 0.6× 54 0.4× 173 1.7× 213 2.2× 11 1.4k
Daniele Marciano Israel 19 779 1.3× 678 1.4× 44 0.3× 157 1.5× 218 2.2× 52 2.0k
Kwan‐Young Jung South Korea 18 562 0.9× 364 0.7× 34 0.2× 62 0.6× 112 1.1× 52 975
Qiong Xie China 20 403 0.7× 382 0.8× 152 1.0× 114 1.1× 145 1.5× 89 1.2k
Sonia Cantel France 19 860 1.4× 247 0.5× 83 0.6× 90 0.9× 79 0.8× 57 1.5k
Derek C. Cole United States 21 1.1k 1.9× 908 1.8× 88 0.6× 272 2.7× 182 1.8× 39 1.9k

Countries citing papers authored by David Orain

Since Specialization
Citations

This map shows the geographic impact of David Orain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Orain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Orain more than expected).

Fields of papers citing papers by David Orain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Orain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Orain. The network helps show where David Orain may publish in the future.

Co-authorship network of co-authors of David Orain

This figure shows the co-authorship network connecting the top 25 collaborators of David Orain. A scholar is included among the top collaborators of David Orain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Orain. David Orain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carcache, David A., Anna Vulpetti, Joerg Kallen, et al.. (2018). Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model. Journal of Medicinal Chemistry. 61(15). 6724–6735. 18 indexed citations
3.
Guntermann, Christine, Alessandro Piaia, Diethilde Theil, et al.. (2017). Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations. JCI Insight. 2(5). e91127–e91127. 41 indexed citations
4.
Weiss, Jessica, Klemens Kaupmann, Joerg Kallen, et al.. (2017). Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo. PLoS ONE. 12(11). e0188391–e0188391. 46 indexed citations
5.
Boettcher, Andreas, Edwige Lorthiois, David Orain, et al.. (2014). Fluorescence Lifetime–Based Competitive Binding Assays for Measuring the Binding Potency of Protease Inhibitors In Vitro. SLAS DISCOVERY. 19(6). 870–877. 8 indexed citations
6.
Koller, Manuel, David A. Carcache, David Orain, et al.. (2012). Discovery of 1H-pyrrolo[2,3-c]pyridine-7-carboxamides as novel, allosteric mGluR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(20). 6454–6459. 5 indexed citations
7.
Briard, Emmanuelle, David Orain, Christian Beerli, et al.. (2011). BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution. ChemMedChem. 6(4). 667–677. 33 indexed citations
8.
Orain, David, Silvio Ofner, Manuel Koller, et al.. (2011). 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(2). 996–999. 16 indexed citations
9.
Koller, Manuel, Kurt Lingenhoehl, Markus Schmutz, et al.. (2011). Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3358–3361. 33 indexed citations
10.
Mattes, Henri, Kumlesh K. Dev, Rochdi Bouhelal, et al.. (2010). Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists. ChemMedChem. 5(10). 1693–1696. 28 indexed citations
11.
Fendt, Markus, Stefan Imobersteg, Kurt Lingenhöhl, et al.. (2009). Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect. Psychopharmacology. 206(2). 291–301. 55 indexed citations
12.
Spanka, Carsten, Ralf Glatthar, Sandrine Desrayaud, et al.. (2009). Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity. Bioorganic & Medicinal Chemistry Letters. 20(1). 184–188. 23 indexed citations
13.
Mattes, Henri, Kurt Lingenhoehl, Hans O. Kalkman, et al.. (2006). AMPA Receptor Antagonists: Potential Therapeutic Applications. PubMed. 1(3). 247–259. 8 indexed citations
14.
Jacoby, Edgar, Ansgar Schuffenhauer, Khalil Azzaoui, et al.. (2005). Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection. Current Topics in Medicinal Chemistry. 5(4). 397–411. 51 indexed citations
15.
Orain, David, et al.. (2005). Concise Synthesis of 1H‐Pyrazin‐2‐ones and 2‐Aminopyrazines.. ChemInform. 36(5). 2 indexed citations
16.
Orain, David, et al.. (2002). Solid-phase template-directed synthesis of a [2]rotaxane using a solid-phase stopper. Chemical Communications. 194–195. 11 indexed citations
17.
Orain, David, et al.. (2002). Efficient Solution and Solid‐Phase Synthesis of a 3,9‐Diazabicyclo[3.3.1]non‐6‐en‐2‐one Scaffold.. ChemInform. 33(52). 162–162. 2 indexed citations
18.
Orain, David & Mark Bradley. (2001). Solid phase synthesis of trypanothione reductase inhibitors—towards single bead screening. Tetrahedron Letters. 42(3). 515–518. 9 indexed citations
19.
Orain, David & Mark Bradley. (2000). A safety-catch linker for amine release under biologically compatible conditions. Molecular Diversity. 5(1). 25–34. 4 indexed citations
20.
Guillier, Fabrice, David Orain, & Mark Bradley. (2000). Linkers and Cleavage Strategies in Solid-Phase Organic Synthesis and Combinatorial Chemistry. Chemical Reviews. 100(6). 2091–2158. 411 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Nuss Breakdown of academic impact, for papers by Pei Xu Breakdown of academic impact, for papers by Giuseppina Sabatino Breakdown of academic impact, for papers by Edward R. Bacon Breakdown of academic impact, for papers by Rebecca L. Maglathlin Breakdown of academic impact, for papers by Daniele Marciano Breakdown of academic impact, for papers by Kwan‐Young Jung Breakdown of academic impact, for papers by Qiong Xie Breakdown of academic impact, for papers by Sonia Cantel Breakdown of academic impact, for papers by Derek C. Cole
Rankless by CCL
2026